Molomics Profile
Molomics

@Molomics

Followers
428
Following
747
Media
67
Statuses
448

Molomics, which integrated Artificial Intelligence with Human Collective Intelligence in real-time, was sold to VeriSIM Life in 2022.

Barcelona, Spain
Joined September 2015
Don't wanna be here? Send us removal request.
@PCB_UB
Parc Científic de Barcelona
3 years
#PCBCommunity | Las operaciones de compra protagonizadas por @Molomics y @Vesismin, con sede en el #PCB_UB, entre los éxitos más relevantes de 2022, según 📰 @ElReferente 📝 Informa @indrakl_ 👇 https://t.co/difeLTgZIJ
Tweet card summary image
elreferente.es
Exits 2022: descubre los que han mercado español. El Referente recopila los datos más relevantes de las operaciones de compra que tuvieron lugar el año pasado.
0
3
3
@VeriSIMlife
VeriSIM Life
3 years
Meet Dr. Nilesh Gupta, VeriSIM Life’s Senior Director of Business Development, at the American Association of Pharmaceutical Scientists’ PharmSci 360 conference in October. Check it out here: https://t.co/c0RdQCt6lG #AAPS #PharmSci #VeriSIMLife
0
1
1
@buruascientifi1
buruascientific
3 years
Take a look to the new articule published by our founder @melsanm. An interesting job to help to discover a new D1R allosteric modulator. A work started, and mainly carried out, when he wroked at @molomics and finished here in Burua!
@melsanm
Melchor
3 years
New article published! We computationally helped to discover a new D1R allosteric modulator. It could be of interest as a promising therapeutic approach for Parkinson's disease. Check it out! https://t.co/cJQZZViX0J #compchem #research #drugdiscovery
0
2
1
@melsanm
Melchor
3 years
New article published! We computationally helped to discover a new D1R allosteric modulator. It could be of interest as a promising therapeutic approach for Parkinson's disease. Check it out! https://t.co/cJQZZViX0J #compchem #research #drugdiscovery
pubs.acs.org
Tolerance development caused by dopamine replacement with l-DOPA and therapeutic drawbacks upon activation of dopaminergic receptors with orthosteric agonists reveal a significant unmet need for safe...
0
2
7
@VeriSIMlife
VeriSIM Life
3 years
Come join our amazing team here at VeriSIM Life. We're hiring mission-driven people for multiple roles including Sales and Engineering! Apply here https://t.co/e28VRu4qkz #careers #diversity #lifescience
0
6
5
@Molomics
Molomics
3 years
Great job @melsanm and great science of the medchem group of @unicomplutense done with the support of @Molomics drug discovery technologies, now part of @VeriSIMlife #drugdiscovery #ArtificialIntelligence #compchem
@buruascientifi1
buruascientific
3 years
New article published! We computationally helped to identified the most potent LPA2 antagonist to date which also exhibits functional selectivity against other LPA receptors (LPA1,3-6). Check it out! https://t.co/XjG65oHciK #compchem #research #drugdiscovery
0
1
2
@VeriSIMlife
VeriSIM Life
3 years
Learn about BIOiSIM, a virtual drug development engine that narrows down potential drugs for specific diseases or illnesses. Read the white paper on VeriSIM Life’s website https://t.co/JV2nVZj9cZ #BIOiSIM #drugdevelopment #VeriSIMLife
0
2
2
@ScienceofPD
The Science of Parkinson's
3 years
New data finds "independent of presynaptic dopamine depletion, the thalamus is a major neural substrate for levodopa-induced dyskinesia & that a contracted thalamic shape at baseline is closely associated with an early development of LID" in #Parkinsons https://t.co/HHPczxVpn0
0
4
8
@AMGWorldEvents
AMG World Events
3 years
We're delighted to share the panel of #AI experts participating in the AI in Drug Development Virtual Roundtable on 26 July at 10:00 - 11:00 ET. Register free today: https://t.co/65tMrMiZ5L @VeriSIMlife @BayerPharma @JanssenGlobal @pfizer
0
2
2
@MayoInvents
Mayo Clinic Ventures
3 years
“This collaboration will explore the full potential of our combined approach to developing best-in-class drug candidates to serve patients’ unmet needs,” said Dr. Jo Varshney, founder and CEO of @VeriSIMlife 🤝 #collaboration #innovation #patientcare
Tweet card summary image
businesswire.com
VeriSIM Life (VeriSIM) www.verisimlife.com, a leading artificial intelligence (AI)-enabled company providing services to de-risk R&D decision making for brea...
0
5
6
@Molomics
Molomics
3 years
Muchas gracias @PCB_UB por todo vuestro apoyo durante muchos años. Estamos muy contentos de juntar nuestros esfuerzos con @VeriSIMlife
@PCB_UB
Parc Científic de Barcelona
3 years
🔹La biotech norteamericana @VeriSIMlife adquiere @Molomics 🔝 La startup culminó en el #PCB_UB el desarrollo de una tecnología #deeptech aplicada al diseño de fármacos innovadores que integra la #InteligenciaColectiva humana con la #InteligenciaArtificial https://t.co/YWal9AvNGm
0
1
4
@dana_klug
Dana Klug
4 years
Congratulations @edwintse_ and the entire OSM team!! 🎉🎉
@O_S_M
Open Source Malaria
4 years
Delighted that @O_S_M's latest paper is now out in @ACSBioMed https://t.co/jliTfFP49V An #openscience competition to compare methods for the #AI #MachineLearning discovery of new molecules for #malaria that were then synthesised and evaluated consistently.
1
4
9
@Molomics
Molomics
4 years
Happy to see that @Molomics recent publication in @jcheminf about #HumanIntelligence has been accessed by more than 1.000 people in 20 days. https://t.co/7zQqLgrnOx #drugdesign #CollectiveIntelligence #medicinalchemist #compchemist
0
1
2
@Molomics
Molomics
4 years
Do you know what @Foldit and @eternagame have to do with the #crowd sourced case study presented here https://t.co/7zQqLgrnOx by @Molomics? #molecule #drugdesign #cheminformatics
0
4
8
@Molomics
Molomics
4 years
. @Molomics will be attending the Discovery Chemistry US event, taking place on the 15-16 November 2021 #online. Looking forward to great talks and lots of discussions with peers. @drugdiscovery1 #drugdesign #AI #cheminformatics #compchem #medchem #collectiveintelligence
0
1
3